Fuse Biotherapeutics: Funding, Investors & Team (Sep 2026)
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues. Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA.
Fuse Biotherapeutics has raised $2.6M across 1 funding round on record, the most recent an undisclosed round of $2.6M announced in Jul 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fuse Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Fuse Biotherapeutics Funding Rounds
Fuse Biotherapeutics Founders and Leadership Team
Contact details for the Fuse Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Fuse Biotherapeutics Funding Compared to Other Biotechnology Startups
Fuse Biotherapeutics' latest round of $2.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fuse Biotherapeutics in Biotechnology and Los Angeles
Companies Similar to Fuse Biotherapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Fuse Biotherapeutics Funding FAQs
What does Fuse Biotherapeutics do?
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers. The company's therapeutic approach integrates the multiple steps of an immune response in a rational manner such that potent responses to danger are targeted without sacrificing natural breaks in the system that spare healthy tissues. Fuse Biotherapeutics was founded in 2021 and is headquartered in Los Angeles, CA.
How much funding has Fuse Biotherapeutics raised?
Fuse Biotherapeutics has raised $2.6M across 1 round on record. The most recent is an undisclosed round of $2.6M announced in Jul 2021.
When did Fuse Biotherapeutics last raise funding?
Fuse Biotherapeutics' most recent funding round on record is an undisclosed round of $2.6M, announced in Jul 2021.
Who is the CEO of Fuse Biotherapeutics?
Paul Song is listed as CEO at Fuse Biotherapeutics.
Where is Fuse Biotherapeutics headquartered?
Fuse Biotherapeutics is based in Los Angeles, California, United States.
How many employees does Fuse Biotherapeutics have?
Fuse Biotherapeutics is in the 1-10 employee band.
How does Fuse Biotherapeutics' funding compare to other Biotechnology startups?
Fuse Biotherapeutics' latest round of $2.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Fuse Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fuse Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.